STOCK TITAN

IQVIA (NYSE: IQV) CFO nets 44,103 direct shares after award

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

IQVIA Holdings executive vice president and chief financial officer Ronald E. Bruehlman reported equity transactions in company common stock on February 8, 2026. He acquired 16,335 shares at $0 per share upon achievement of performance criteria tied to performance-based restricted stock units granted on February 13, 2023, after the company’s Leadership Development and Compensation Committee determined those conditions were satisfied.

On the same date, he disposed of 6,801 shares of common stock in a transaction coded “F” at $187.49 per share. Following these transactions, Bruehlman directly owned 44,103 shares of IQVIA common stock and indirectly owned an additional 11,893 shares through the Ronald E. Bruehlman Revocable Trust.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bruehlman Ronald E

(Last) (First) (Middle)
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD

(Street)
DURHAM NC 27703

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
02/08/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/08/2026 A 16,335(1) A $0 50,904 D
Common Stock 02/08/2026 F 6,801 D $187.49 44,103 D
Common Stock 11,893 I By Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026.
2. Shares held in Ronald E. Bruehlman Revocable Trust.
Remarks:
EVP & Chief Financial Officer
/s/ Matthew Gilmartin, Attorney-in-Fact for Ronald E Bruehlman 02/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did IQV (IQVIA Holdings Inc.) report for Ronald E. Bruehlman?

Ronald E. Bruehlman reported acquiring 16,335 IQVIA common shares at $0 per share and disposing of 6,801 shares at $187.49 per share. After these transactions, he held 44,103 shares directly and 11,893 shares indirectly via a revocable trust.

How many IQVIA (IQV) shares does CFO Ronald E. Bruehlman own after this Form 4?

After the reported transactions, Ronald E. Bruehlman directly owned 44,103 IQVIA common shares and indirectly owned 11,893 shares through the Ronald E. Bruehlman Revocable Trust. These holdings reflect both the new performance-based award and the same-day share disposition.

What was the nature of the 16,335 IQVIA shares acquired by Ronald E. Bruehlman?

The 16,335 IQVIA shares were acquired at $0 per share upon achieving performance criteria tied to performance-based restricted stock units granted on February 13, 2023. The company’s Leadership Development and Compensation Committee determined those performance conditions were satisfied on February 8, 2026.

At what price were the 6,801 IQVIA shares disposed of by Ronald E. Bruehlman?

Ronald E. Bruehlman disposed of 6,801 IQVIA common shares at a price of $187.49 per share in a transaction coded “F” on February 8, 2026. This transaction reduced his directly held shares to 44,103 afterward.

How many IQVIA (IQV) shares does Ronald E. Bruehlman hold indirectly and through what entity?

Ronald E. Bruehlman indirectly holds 11,893 IQVIA common shares through the Ronald E. Bruehlman Revocable Trust. The Form 4 identifies these as indirectly owned shares, separate from his directly held 44,103 shares after the reported transactions.

What role does the IQVIA Leadership Development and Compensation Committee play in these awards?

The Leadership Development and Compensation Committee determined that performance conditions for Bruehlman’s February 13, 2023 performance-based restricted stock units were satisfied on February 8, 2026. That decision triggered the acquisition of 16,335 IQVIA common shares at $0 per share under the award’s terms.
Iqvia Hldgs Inc

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Latest SEC Filings

IQV Stock Data

28.72B
167.84M
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
DURHAM